Since previous studies have demonstrated that c-met and MCL-1 regulate TRAIL sensitivity to several cancers [21, 22], we next investigated whether expression levels of c-met and MCL-1 were associated with TRAIL sensitivity to our PTC cell line TPC-1. Here, MET is linked to cancer.